Ming‐Te Kuo

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

Ming‐Te Kuo, Tsung‐Hui Hu, Chao‐Hung Hung et al. · Alimentary Pharmacology & Therapeutics · 2018 · 74 citations · Full text

Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease

Ming‐Te Kuo, Shih‐Cheng Yang, Lung‐Sheng Lu et al. · BMC Gastroenterology · 2015 · 21 citations · Full text

Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C

Ming‐Te Kuo, Tsung‐Hui Hu, Sheng‐Nan Lu et al. · Disease Markers · 2014 · 13 citations · Full text

Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy

Ming‐Te Kuo, Po‐Lin Tseng, Yeh‐Pin Chou et al. · Journal of Gastroenterology and Hepatology · 2018 · 11 citations

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease

Chih‐Ming Liang, Ming‐Te Kuo, Pin‐I Hsu et al. · World Journal of Gastroenterology · 2017 · 10 citations